| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Surgery | 256 / 597 | 57th | Q2 |
| Anesthesiology and Pain Medicine | 64 / 147 | 56th | Q2 |
| Oncology (nursing) | 14 / 24 | 43rd | Q3 |
| Pharmacology (medical) | 176 / 278 | 36th | Q3 |
| Oncology | 278 / 428 | 35th | Q3 |
| Cancer Research | 187 / 233 | 19th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Precision Cancer Medicine
Precision Cancer Medicine is Scopus-indexed (Q2, CiteScore 2.5). Published by AME Publishing Company.
Checked against the index lists dated .
ISSN 2617-2216Verify ISSN ↗
Publisher: AME Publishing Company
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Precision Cancer Medicine indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2018–2025, best quartile Q2, CiteScore 2.5.
What quartile is Precision Cancer Medicine in Scopus?
Precision Cancer Medicine is Q2 in Surgery (rank 256 of 597), Q2 in Anesthesiology and Pain Medicine (rank 64 of 147) and Q3 in Oncology (nursing) (rank 14 of 24), by CiteScore 2025. It is ranked in 6 subject areas in all.
What is the impact factor of Precision Cancer Medicine?
Precision Cancer Medicine is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.5, quartile Q2, 57th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.390, quartile Q2, with an H-index of 11.
Who publishes Precision Cancer Medicine and what is its ISSN?
Precision Cancer Medicine is published by AME Publishing Company. Its ISSN is 2617-2216.
Is Precision Cancer Medicine in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Precision Cancer Medicine open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Precision Cancer Medicine? — open metrics via OpenAlex
Precision Cancer Medicine has an h-index of 13 and a 2-year mean of 2.67 citations per paper (OpenAlex). Its Scopus CiteScore is 2.5, quartile Q2. On 2-year citations it ranks #58 of 585 Scopus journals in Surgery.
Precision Cancer Medicine published 1 papers in 2025; its busiest recent year was 2021 with 71. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Precision Cancer Medicine? — latest 89 articles, 2021–2025
In its latest 89 research articles (2021–2025), authors are most often from Italy (28.7%), United States (24.3%) and China (9.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Precision Cancer Medicine? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.